On the morning of August 27, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by S. Leigh Verbois, Country Director of U.S. FDA China Office. Both sides exchanged opinions on the integrity of drug clinical trial data, China's reform of drug evaluation and approval system, and the exchanges and cooperation in drug regulatory systems between both countries.